Polymerase Chain Reaction (PCR) Consumables Market, By Product (PCR Tubes, PCR Microplates, Cap/Lids), Technology (Real Time, Digital, Traditional), Application (Research, Clinical), End-use (Hospital, Diagnostic Labs, CROs) – Global Forecast (2024 – 2032)

Polymerase Chain Reaction Consumables Market Size

Polymerase chain reaction (PCR) consumables market size was valued at around USD 530.5 million in 2023 and is estimated to grow at 4.8% CAGR from 2024 to 2032. Polymerase chain reaction consumables are essential components used in the process of PCR, a widely used molecular biology technique for amplifying DNA sequences. The consumables encompass various materials and reagents necessary for conducting PCR reactions efficiently and accurately.
 

The rising investments in life sciences research geriatric population is a significant driver for the polymerase chain reaction consumables industry. Technological advancements and innovations in life sciences research have expanded the applications of PCR, driving demand for PCR consumables. For instance, according to the National Library of Medicine, in 2024, the emergence of real-time PCR and digital PCR technologies has enabled more sensitive, quantitative, and high-throughput analyses of nucleic acids, leading to increased adoption of PCR consumables in research laboratories and diagnostic facilities. As pharmaceutical companies invest in these areas to identify novel drug targets, develop personalized therapies, and streamline drug testing processes, the demand for PCR consumables grows correspondingly.
 

Moreover, increasing prevalence of infectious diseases, rising adoption of biochemical reagents (market size is estimated to account for USD 50.4 billion by the end of year 2032), growing awareness about PCR & NGS based diagnostic testing, rising healthcare expenditure globally, government initiatives and funding, and increasing education & awareness, are the stimulating factors fostering the growth of the market.
 

Polymerase Chain Reaction (PCR) Consumables Market Trends

The increasing prevalence of infectious diseases is a significant driver for polymerase chain reaction (PCR) consumables industry. PCR-based assays are highly sensitive, specific, and versatile, making them invaluable tools for the detection and characterization of infectious agents such as viruses, bacteria, fungi, and parasites.
 

• According to the World Health Organization (WHO), in 2023, there are more than 39 million people suffering from HIV. As per the same report, HIV prevalence is the largest among adult males and is surging at a rapid pace.
   
• Similarly, according to the National Institutes of Health, in 2022, number of new tuberculosis cases rose to 8,916 in the U.S. Further, number of new salmonella cases jumped to 58,371 in the country. Thus, leading to increase in respiratory disease testing, ultimately utilizing the PCR consumables.
   
• Infectious disease outbreaks, epidemics, and pandemics pose significant public health challenges and require rapid response measures to contain transmission and mitigate impact. PCR technology enables rapid and reliable detection of infectious agents in clinical samples, environmental samples, and surveillance systems.
   
• The emergence and re-emergence of infectious pathogens, including novel viruses, antibiotic-resistant bacteria, and zoonotic infections, drive the need for advanced diagnostic tools capable of detecting and characterizing these pathogens. Consequently, there is a growing demand for PCR consumables to support research, surveillance, and diagnostic activities related to emerging infectious diseases.
   

Polymerase Chain Reaction Consumables Market Analysis

Based on product, the market is segmented into PCR tubes, PCR microplates, cap/lids, and other products. The PCR tubes segment is estimated to account for USD 352.3 million by the end of 2032.
 

• PCR tubes are essential components used to hold the PCR reaction mixture during amplification. They are widely used across various PCR applications, including gene expression analysis, DNA sequencing, genotyping, infectious disease diagnosis, forensic analysis, and molecular biology research. The versatility and ubiquity of PCR tubes across different laboratory settings contribute to their significant market share.
   
• They are compatible with a wide range of PCR instruments, including thermal cyclers, real-time PCR systems, digital PCR systems, and multiplex PCR systems. They come in various formats and sizes to accommodate different PCR platforms and reaction volumes, ensuring compatibility and ease of use for researchers and laboratory technicians.
   
• Moreover, these tubes are typically designed to be lightweight, transparent, and easy to handle, allowing for efficient sample loading, sealing, and storage. They may feature thin-walled construction to ensure rapid and uniform heat transfer during thermal cycling, resulting in optimal PCR performance and reproducibility.
   
• Further, PCR tubes are often disposable, single-use consumables, reducing the risk of sample cross-contamination and minimizing the need for cleaning and sterilization between experiments. Thus, driving their widespread adoption in research and clinical laboratories and accelerating the segmental growth.

Based on technology, the polymerase chain reaction (PCR) consumables market is divided into real time PCR, digital PCR, and traditional PCR. The real time PCR segment accounted for USD 248.1 million in 2023.
 

• Real-time PCR offers exceptional sensitivity and specificity, allowing for the detection and quantification of target nucleic acids with high accuracy and precision. This makes it suitable for a wide range of applications, including gene expression analysis, pathogen detection, mutation analysis, and viral load quantification.
   
• One of the primary advantages of real-time PCR is its ability to quantify the amount of target DNA or RNA present in a sample. This quantitative capability is crucial for various research and diagnostic applications, such as determining gene expression levels, measuring viral load in infectious diseases, and monitoring disease progression or treatment response.
   
• Further, real-time PCR assays typically produce results rapidly, often within a few hours or less, compared to traditional PCR methods. This rapid turnaround time is advantageous for time-sensitive applications, such as diagnostic testing, outbreak investigations, and research studies requiring high-throughput analysis.
   
• Real-time PCR instruments are often automated and capable of high-throughput analysis, allowing for the simultaneous processing of multiple samples in a single run. This automation streamlines workflow, reduces hands-on time, and increases throughput, making real-time PCR ideal for large-scale screening, surveillance, and research studies.
   
• Thus, such aforementioned factors are expected to augment the segmental growth.
   

Based on application, market is divided into research and clinical. The clinical segment accounted for a market share of 64.2% in 2023.
 

• PCR consumables is widely used in clinical diagnostics for the detection and quantification of nucleic acids from pathogens, genetic mutations, and disease biomarkers. For instance, they are essential for diagnosing infectious diseases, genetic disorders, cancer, and other medical conditions, driving demand for PCR consumables in clinical laboratories and diagnostic facilities.
   
• Moreover, PCR-based tests are utilized in population-based screening and surveillance programs for infectious diseases, such as HIV, hepatitis, influenza, and sexually transmitted infections. These programs aim to identify asymptomatic carriers, track disease prevalence, and implement public health interventions to prevent disease transmission and outbreaks.
   
• PCR technology plays a critical role in genetic testing and personalized medicine by enabling the detection of genetic variations, mutations, and polymorphisms associated with inherited disorders, pharmacogenomics, and cancer predisposition. PCR-based tests provide valuable information for disease risk assessment, treatment selection, and patient management in clinical settings.
   
• Regulatory clearance and standardization of PCR-based tests ensure assay reliability, reproducibility, and compliance with quality standards, fostering confidence among healthcare providers and facilitating market growth in the clinical segment.
   

Based on end-use, the polymerase chain reaction consumables market is segmented into hospitals and clinical diagnostic laboratories, pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs), and other end-users. The hospitals and clinical diagnostic laboratories segment held a market size of USD 177.7 million in the year 2023.
 

• Hospitals and clinical diagnostic laboratories perform a large volume of PCR-based tests for various diagnostic applications, including infectious diseases, genetic disorders, oncology, and personalized medicine. The demand for PCR consumables, such as reagents, kits, and disposables, is driven by the need to support routine diagnostic testing, screening programs, and specialized molecular assays.
   
• These settings offer a wide range of PCR-based tests to meet the diagnostic needs of patients across different medical specialties and disease areas. PCR assays are utilized for pathogen detection, viral load monitoring, genetic testing, mutation analysis, and pharmacogenomics, among other applications, driving demand for PCR consumables tailored to specific testing requirements.
   
• Many hospitals and large clinical laboratories operate centralized testing facilities equipped with state-of-the-art PCR instrumentation and automation platforms. These centralized facilities serve as hubs for PCR testing services, providing economies of scale, operational efficiency, and standardized testing protocols. Thus, leading to higher adoption of consumables.
   
• They often collaborate with academic institutions, research organizations, and biotechnology companies to develop and validate novel PCR assays for clinical diagnostics and research applications. These collaborative efforts stimulate innovation, technology transfer, and the adoption of advanced PCR consumables in clinical settings, contributing to market growth in the hospitals and clinical diagnostic laboratories segment.

U.S. polymerase chain reaction (PCR) consumables market is anticipated to grow at CAGR of 4.4% during the analysis timeframe.
 

• The country has a high prevalence of infectious diseases, including respiratory infections, sexually transmitted infections, and healthcare-associated infections. PCR-based tests are widely used for disease diagnosis, monitoring, and surveillance, contributing to the demand for PCR consumables.
   
• For instance, according to the National Institutes of Health, in 2022, there were 32,100 estimated new HIV infections in the U.S. and the rate was 11.5 (per 100,000 people).
   

Germany market is anticipated to witness lucrative growth between 2024 – 2032.
 

• Germany is a global leader in biotechnology and life sciences, with a well-established ecosystem of research institutions, universities, biotech companies, and healthcare facilities.
   
• The country's robust biotechnology sector fosters innovation, research collaborations, and technology transfer, driving demand for PCR consumables for molecular diagnostics, genetic testing, and research applications.
   

Japan polymerase chain reaction consumables market is expected to grow significantly over the years.
 

• The country is known for its technological innovation and research excellence in molecular biology, genetics, and medical sciences. Japanese researchers and institutions have made significant contributions to PCR technology and its applications, including the development of novel assays, instrumentation, and consumables.
   

UAE polymerase chain reaction consumables industry is anticipated to witness lucrative growth between 2024 – 2032.
 

• UAE has made significant investments in healthcare infrastructure, including the development of state-of-the-art hospitals, clinics, and research facilities equipped with advanced diagnostic equipment and technologies. PCR technology is widely used in the UAE for clinical diagnostics, infectious disease surveillance, genetic testing, and research, driving demand for PCR consumables.
   
• Further, the UAE's strategic location in the Middle East, along with its excellent air and sea connectivity, positions it as a regional hub for trade, commerce, and healthcare services. The country serves as a gateway to the broader Middle East and North Africa (MENA) region, facilitating the distribution and adoption of PCR consumables across multiple markets.
   

Polymerase Chain Reaction Consumables Market Share

The polymerase chain reaction (PCR) consumables industry is highly competitive, marked by several players striving for market dominance. Providers offer comprehensive products with improved efficiency and affordability. This includes advancements in structure, materials used, data reporting, sensor design, and customization. Competition is driven by factors such as the quality, reliability, performance, cost, and compliance with regulatory standards. Strategic partnerships with companies and healthcare networks play a crucial role in market positioning.
 

Polymerase Chain Reaction Consumables Market Companies

Some of the eminent market participants operating in the polymerase chain reaction consumables industry include:

• Abbott Laboratories
• Agilent Technologies, Inc.
• Analytik Jena AG
• Becton, Dickinson and Company
• Bioer Technology Co., Ltd.
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• Merck KGaA
• New England Biolabs, Inc.
• Promega Corporation
• QIAGEN N.V.
• Takara Bio Inc.
• Thermo Fisher Scientific, Inc.
   

Polymerase Chain Reaction (PCR) Consumables Industry News:

• In May 2024, QIAGEN N.V. announced a cooperative research and development agreement (CRADA) with the U.S. Federal Bureau of Investigation (FBI) to develop a novel test for its QIAcuity digital PCR devices that will PCR tubes and microplates. Thus, the collaboration will escalate the consumables, thereby, stimulating the business growth of the company.
   
• In November 2022, Danaher Corporation through its subsidiary, Cepheid launched Xpert Xpress MVP, a multiplexed PCR test that detects DNA from organisms associated with three distinct conditions, bacterial vaginosis (BV), vulvovaginal candidiasis, and trichomoniasis, from a single sample, aiding in more accurate diagnosis and antibiotic treatment regimens. This increased the utilization of the consumables (plates, tubes, and caps) and thereby enhanced the market’s revenue.
   

The polymerase chain reaction (PCR) consumables market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• PCR tubes
• PCR microplates
• Cap/lids
• Other products

Market, By Technology

• Real time PCR
• Digital PCR
• Traditional PCR

Market, By Application

• Research
• Clinical

Market, By End-use

• Hospitals and clinical diagnostic laboratories
• Pharmaceutical and biotechnology companies
• Academic and research institutes
• Contract research organizations (CROs)
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa